News

Cancer Research17d
Abstract CT107: A phase 1a/b, open-label, dose-escalation study of
Search for other works by this author on: ...
Yahoo Finance18d
CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025
Title: ROSELLA: A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Patients with Platinum-Resistant Ovarian Cancer (GOG-3073, ENGOT-ov72 ...
Business Wire18d
CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025
will present data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the 2025 American Society of Clinical Oncology ...
Yahoo Finance18d
CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025
Title: ROSELLA: A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Patients with Platinum-Resistant Ovarian Cancer (GOG-3073, ENGOT-ov72) The ...
C&EN20d
Improved Dispersion of Micron-Sized Platinum Powder through Heat Treatment
Chongqing Materials Research Institute Co., Ltd, No. 8, Jiade Road, Caijiagang Town, Beibei, Chongqing 400707, China National Engineering Research Center for ...
C&EN22d
Efficient Determination of Water/Ice Phase Diagram through Isenthalpic–Isobaric Molecular Dynamics Simulations
Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo (USP), Av. Prof. Luciano Gualberto, 380, São Paulo, São Paulo 05508-010, Brazil ...